Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
The diagnosis and treatment of sphincter of Oddi dysfunction (SOD) presents a significant challenge. This chapter is intended to provide readers with a practical guide to the evaluation and management of patients with pancreaticobiliary-type pain and suspected SOD by providing a pragmatic approach to the clinical evaluation and decisions regarding treatment. The specific goals are to (1) describe pancreaticobiliary pain patterns; (2) define SOD and the clinical presentations in which SOD should be considered; (3) describe a rational initial evaluation for patients with suspected SOD; (4) provide guidance for physician decisions regarding management of SOD; (5) describe techniques of sphincter of Oddi manometry (SOM) and endoscopic treatment of SOD; and (6) reinforce the risks inherent to the patient undergoing endoscopic evaluation of SOD and how these risks can be minimized. It should be emphasized that until recently, there has been a paucity of quality data to guide clinicians in this arena, especially on type III patients. There are now more robust data available to derive evidence-based recommendations.
Clinical syndromes that may be attributed to SOD range from functional disorders with purely subjective symptomatology to structural disorders having objective pathologic features. Functional and structural SOD diagnoses are widely divergent with regard to their presentation and management. Unexplained upper abdominal pain and idiopathic acute recurrent pancreatitis represent the most important examples at each end of this spectrum; this review will focus on unexplained upper abdominal pain, a functional disorder. Other clinical scenarios that may be associated with SOD include chronic acalculous cholecystitis, early chronic pancreatitis, biliary pancreatitis, postoperative bile leak, and pancreatic fistula.
Confusing terminology and varied clinical presentations partly explain the complexity regarding SOD. Biliary dyskinesia is the encompassing term for a group of disorders with acalculous biliary-type pain. Subgroup diagnoses include chronic acalculous cholecystitis, gallbladder dyskinesia, cystic duct syndrome, and SOD. SOD may occur in patients with or without a gallbladder but is most commonly diagnosed in patients with postcholecystectomy symptoms.
Attempts have been made to develop consensus on defining the signs and symptoms of SOD, culminating in the latest iteration of the Rome criteria (Rome IV). Diagnostic criteria for biliary pain and functional gallbladder disorders are listed in Box 47.1 . The Rome criteria are meant to provide a general framework for clinicians but obviously do not describe all patients. A unifying symptom, present in all patients with SOD, is pain. When evaluating a patient with possible SOD, the most important aspect of the evaluation is the history. It is imperative that the clinician gain a clear understanding of the nature, location, and timing of pain. The Rome criteria specify that the pain should be intermittent, with pain-free intervals. Although typical biliary pain is classically intermittent, in some cases patients will have constant low-grade discomfort with exacerbations. The concept of chronic biliary pain is thought to be related to heightened visceral hypersensitivity, altered central nervous system processing, and/or generalized motility disorders. Patients with more persistent pain should undergo careful review and extensive evaluation for other causes of pain ( Box 47.2 ) but should not be arbitrarily excluded from evaluation for SOD based solely on there being a constant component to their pain. However, if associated symptoms such as nausea, vomiting, abdominal distension, or bowel dysfunction are dominant, the patient likely does not have SOD. Based on observations and after developing correlations between patients' presentations and outcomes after endoscopic sphincterotomy, Joseph Geenen, Walter Hogan, and Wylie Dodds published what have come to be known as the Geenen-Hogan (G-H) criteria ( Table 47.1 ). These have been modified over the years but provide a guide for clinicians to direct their evaluation and decision making. The original criteria were applied to patients who had previously undergone cholecystectomy and were based on three factors that could be assessed without endoscopic retrograde cholangiopancreatography (ERCP): (1) presence of “typical” pancreatic-type or biliary-type pain, (2) presence or absence of elevated liver or pancreas tests during or shortly after an episode of pain (that returned to normal when the pain subsided), and (3) presence or absence of bile and/or pancreatic duct dilation. The original criteria also included measurement of pancreatic and biliary drainage times, but these are no longer considered valid.
Pain located in the epigastrium and/or right upper quadrant and all of the following:
Builds up to a steady level and lasts 30 minutes or longer
Occurs at different intervals (not daily)
Severe enough to interrupt daily activities or lead to an emergency department visit
Not significantly (<20%) related to bowel movements
Not significantly (<20%) relieved by postural change or acid suppression
Supportive criteria include the pain is associated with:
Nausea and vomiting
Radiation to the back and/or right infra-subscapular region
Waking from sleep
Biliary pain
Absence of gallstones or other structural pathology
Supportive criteria:
Low ejection fraction on gallbladder scintigraphy
Normal liver enzymes, conjugated bilirubin, and amylase/lipase
Esophageal
Spasm or other motility disorder
Esophagitis
Gastric
Gastroparesis
Ulcer
Hiatal hernia
Volvulus
Pyloric stenosis
Duodenal
Stricture
Ulcer
Diverticulitis
Ampullary neoplasm
Biliary
Stone
Benign stricture
Sump syndrome
Neoplasm
Pancreatic
Chronic pancreatitis
Neoplasm
Abdominal wall
Neuroma
Myopathy/myositis
Irritable bowel syndrome
Type | Typical Pain | LFT >2X Normal | BD Diameter >10 mm |
---|---|---|---|
I | + | + | + |
II | + | + | − |
II | + | − | + |
III | + | − | − |
The G-H criteria defined three subtypes and are important because they represent a framework around which a clinician can plan patient evaluation. If one obtains an appropriate history of pain, bile duct imaging should be obtained and the patient should be given a prescription directing health care providers (in an emergency room, hospital laboratory, or clinic) to obtain a liver panel and pancreatic tests (amylase and/or lipase) during or shortly after a pain episode. These data then can be used to stratify patients as to their likelihood of having SOD.
The first step is a detailed review of prior health care encounters pertinent to the clinical presentation, with a focus on questions of when, where, and what ( Box 47.3 ). A complete history and thorough review of records will define the clinical symptoms, reveal what tests have been done, what treatments (surgical, endoscopic, medical) have been tried, and what the impact has been on the patient. Patients with unexplained symptoms that may be attributed to SOD often end up undergoing a massive assault, which may diagnostic and therapeutic. It can be helpful to organize objective data regarding prior laboratory testing, imaging, and treatments ( Box 47.4 ).
When did the attacks begin?
When do the attacks occur?
Where is the pain?
Where does the pain radiate?
What is associated with the attacks?
What has been done to investigate the cause?
What has been done to treat the attacks?
What are the consequences of the attacks?
Serum liver and pancreas chemistries
Serum fasting triglyceride
Gallbladder pathology
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here